HomeGDTC • NASDAQ
add
CytoMed Therapeutics Ltd
Previous close
$2.15
Day range
$2.15 - $2.18
Year range
$1.92 - $9.25
Market cap
24.79M USD
Avg Volume
7.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(SGD) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 142.11K | 281.29% |
Operating expense | 1.15M | 155.58% |
Net income | -1.08M | -116.83% |
Net profit margin | -759.30 | 43.13% |
Earnings per share | — | — |
EBITDA | -913.24K | -184.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SGD) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.44M | 594.69% |
Total assets | 13.91M | 170.01% |
Total liabilities | 746.07K | -79.24% |
Total equity | 13.17M | — |
Shares outstanding | 11.53M | — |
Price to book | 1.89 | — |
Return on assets | -18.23% | — |
Return on capital | -18.60% | — |
Cash Flow
Net change in cash
(SGD) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -1.08M | -116.83% |
Cash from operations | -1.02M | -319.49% |
Cash from investing | -8.56K | 95.94% |
Cash from financing | 5.46M | 10,976.46% |
Net change in cash | 4.43M | 963.69% |
Free cash flow | -554.00K | -40.26% |
About
Founded
2018
Website
Employees
28